Every S-3 that Microvision (MVIS) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A S-3 covers the shelf registration that lets an established company sell over time, so if you follow MVIS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full MVIS filings page.
MicroVision, Inc. has filed a shelf registration statement that permits it to offer, from time to time after effectiveness, up to $50,000,000 of common stock, preferred stock, warrants and subscription rights through various transaction types, including underwritten, direct, and at-the-market offerings of common stock.
Net proceeds from any offerings are expected to be used for general corporate purposes, including working capital and capital expenditures. As of June 30, 2026, 350,250,363 common shares were outstanding out of 510,000,000 authorized, and the Nasdaq closing price was $0.38 per share on July 10, 2026.
MicroVision develops lidar-based perception solutions for automotive, industrial, and security & defense markets and has expanded its portfolio through acquisitions of assets from Ibeo, Scantinel Photonics, and Luminar’s lidar business. The company reports a history of significant losses and states that investments in its securities involve a high degree of risk.
MicroVision, Inc. is registering an at-the-market equity program to offer up to $42,000,000 of common stock pursuant to an amended Sales Agreement with Deutsche Bank Securities Inc., Mizuho Securities USA LLC and Craig-Hallum Capital Group LLC, effective June 12, 2026. The offering may be conducted from time to time through the Sales Agents, who will receive a 3% commission on sales.
The prospectus uses an illustrative price of $0.36 per share (last reported sale on June 11, 2026). Shares outstanding were 344,645,965 as of May 28, 2026; the prospectus shows a pro forma example assuming issuance of 116,666,666 shares (resulting in up to 461,312,631 shares outstanding). The company states proceeds will be used for general corporate purposes and warns of immediate dilution to new investors.
MicroVision, Inc. files a pre-effective Amendment No. 1 to register for resale up to 61,315,970 shares of common stock underlying senior secured convertible notes due 2028 (the "Convertible Notes") held by High Trail Special Situations LLC and High Trail Special Situations II LLC. The registrant will receive no proceeds from resales. The shares are issuable upon conversion of Convertible Notes issued in a private placement on February 23, 2026, which aggregate principal was approximately $43 million. The Convertible Notes include an initial conversion price of $0.8819 per share, a 4.99% beneficiary ownership limit (increaseable to 9.99% with notice), monthly partial redemptions at holder election, and a Forced Conversion feature tied to a $2.00 VWAP trigger. Shares outstanding were 326,982,727 as of April 20, 2026; assuming conversion of all registered Shares, the prospectus states 388,298,697 shares outstanding. The prospectus discloses risks related to volatility, dilution, secured debt, liquidity covenants and collateralized bank and securities accounts.
MicroVision, Inc. registers up to 61,315,970 shares of common stock underlying senior secured convertible notes due 2028 (the "Convertible Notes"). These Shares are issuable upon conversion of the Convertible Notes and are being registered for resale by the selling stockholders.
The company will receive no proceeds from sales by the selling stockholders. The prospectus discloses 326,982,727 shares outstanding as of April 20, 2026 and states a pro forma figure of 388,298,697 common shares outstanding assuming all Shares offered herein are issued pursuant to conversion of the Convertible Notes.